Oryza Pharmaceuticals Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Series C
- Investors
-
5
Oryza Pharmaceuticals General Information
Description
Developer of innovative drugs designed to provide better treatment for patients. The company offers research and development of innovative drugs for diabetes, digestive system diseases, cardiovascular and cerebrovascular diseases, malignant tumors, and the pharmaceutical preparations process, thereby providing advanced treatment solutions for medical industrial users.
Contact Information
Website
www.oryzapharma.com.cnCorporate Office
- Room 853, Building B, Wanhe Technology Building, No. 7 Huitong Road, Fenghuang Community
- Fenghuang Street, Guangming District
- Shenzhen, Guangdong
- China
Corporate Office
- Room 853, Building B, Wanhe Technology Building, No. 7 Huitong Road, Fenghuang Community
- Fenghuang Street, Guangming District
- Shenzhen, Guangdong
- China
Oryza Pharmaceuticals Timeline
Oryza Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series C) | 29-Dec-2025 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Private | 30-Dec-2025 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 27-Aug-2024 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B1) | 21-Nov-2023 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 19-May-2021 | $3.09M | $3.09M | Completed | Generating Revenue | |
| 1. Corporate | 13-Jun-2018 | Completed | Generating Revenue |
Oryza Pharmaceuticals Signals
Oryza Pharmaceuticals Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| China Venture Capital | Venture Capital | Minority | ||
| Feixi County Industrial Park Investment Holding (Group) | Venture Capital | Minority | ||
| ASB Ventures | Venture Capital | Minority | ||
| Cowin Capital | Venture Capital | Minority | ||
| Goldport Capital | Venture Capital | Minority |
Oryza Pharmaceuticals FAQs
-
When was Oryza Pharmaceuticals founded?
Oryza Pharmaceuticals was founded in 2016.
-
Where is Oryza Pharmaceuticals headquartered?
Oryza Pharmaceuticals is headquartered in Shenzhen, China.
-
What is the size of Oryza Pharmaceuticals?
Oryza Pharmaceuticals has 14 total employees.
-
What industry is Oryza Pharmaceuticals in?
Oryza Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Oryza Pharmaceuticals a private or public company?
Oryza Pharmaceuticals is a Private company.
-
What is Oryza Pharmaceuticals’s current revenue?
The current revenue for Oryza Pharmaceuticals is .
-
How much funding has Oryza Pharmaceuticals raised over time?
Oryza Pharmaceuticals has raised $4.47M.
-
Who are Oryza Pharmaceuticals’s investors?
China Venture Capital, Feixi County Industrial Park Investment Holding (Group), ASB Ventures, Cowin Capital, and Goldport Capital have invested in Oryza Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process